NewAmsterdam Pharma Co N.V. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Narrden, Netherlands
SEC filing record 1 source field available
Fiscal year end
31 December
NewAmsterdam Pharma Co N.V. has filed 399 SEC EDGAR filings since 04 Aug 2022

SEC filing history

Showing 1-25 of 27 matching filings.

Per page
25
Current page
1
6-K File 001-41562

6-K

Filing date
13 Nov 2023
Reporting date
13 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
23 Oct 2023
Reporting date
23 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
25 Sep 2023
Reporting date
25 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
21 Sep 2023
Reporting date
21 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
28 Aug 2023
Reporting date
28 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
14 Aug 2023
Reporting date
14 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
07 Aug 2023
Reporting date
07 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
26 Jul 2023
Reporting date
26 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
21 Jun 2023
Reporting date
21 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
12 Jun 2023
Reporting date
09 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
05 Jun 2023
Reporting date
05 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
31 May 2023
Reporting date
31 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
23 May 2023
Reporting date
23 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
08 May 2023
Reporting date
08 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
24 Apr 2023
Reporting date
24 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

FORM 6-K

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
31 Mar 2023
Reporting date
31 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
07 Mar 2023
Reporting date
07 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
03 Mar 2023
Reporting date
03 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
14 Feb 2023
Reporting date
14 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
06 Feb 2023
Reporting date
06 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
17 Jan 2023
Reporting date
17 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

6-K

Filing date
11 Jan 2023
Reporting date
11 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-41562

FORM 6-K

Filing date
09 Jan 2023
Reporting date
09 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .